2019 Bloom Burton & Co. Healthcare Investor Conference
April 30, 2019-May 1, 2019
Metro Toronto Convention Centre - 255 Front St W, Toronto











THE CONFERENCE
You are now leaving Bloom Burton & Co. and linking to a third-party website. Bloom Burton & Co. assumes no liability for the content of this linked site and the material it presents, including without limitation, the accuracy, subject matter, quality or timeliness of the content. The fact that this link has been provided does not constitute an endorsement, authorization, sponsorship by or affiliation with Sprott with respect to the linked site or the material.
Metro Toronto Convention Centre - 255 Front St W, Toronto
THE CONFERENCE
Brad Loncar is an independ ent biotechnology investor and CEO of Loncar Investments, a firm that specializes in the creation of thema tic biotechnology investment indexes. Its first two products are The Cancer Immunotherapy Index and The China BioPharma Index. Mr. Loncar previously worked in the financial services industry at Franklin Templeton Investments, where he was a member of the Management Training Program, and was appointed to serve in a Senior Advisor role at the U .S. Department of the Treasury. He currently writes biotechnology commentary at www.LoncarBlog.com and has contributed
opinion pieces to Endpoints News and Xconomy.com.
He is one of the most followed commentators in biotech on social media. With a focus on oncology, Loncar Investments is an official charitable partner of the Cancer Research Institute.